HIV & AIDS

Naltrexone implant helps HIV patients prevent opioid relapse

(HealthDay)—Slow-release implantable naltrexone is associated with better outcomes than the oral drug for HIV-positive patients with an opioid addiction, according to a study published in the April issue of The Lancet HIV.

Obstetrics & gynaecology

In pregnancy, buprenorphine use up, methadone use down

(HealthDay)—From 2009 to 2015, the prevalence of methadone use decreased and buprenorphine use increased among Medicaid-enrolled pregnant women with opioid use disorder, and the 4Ps Plus and Substance Use Risk Profile-Pregnancy ...

Medications

Don't suddenly stop taking a prescribed opioid, FDA warns

(HealthDay)—Because of the danger of "serious harm" to patients, the U.S. Food and Drug Administration is advising doctors not to suddenly stop patients from taking opioid painkillers, or drastically lower the dose.

Medications

Canada opioid deaths top 10,000

More than 10,000 Canadians have died of opioid-related overdoses since a public health crisis erupted in 2016, according to new data released Wednesday.

Medications

Experimental drug shows promise for opioid withdrawal symptoms

While medicines are available to relieve withdrawal symptoms in people recovering from opioid addiction, they cause side effects and can maintain the brain changes that led to addiction in the first place, which can lead ...

page 37 from 40